Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 6/20 | 0.53 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | TAS2R31 | P59538 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29688602 | 0.81 | PTPN1 (0.55) | PTPN1ALOX15ALOX12CYP19A1ALDH1A1 | |
| (3R)-Sativanone SCHEMBL29576626 | 0.80 | PTPN1 (0.61) | PTPN1ALOX15ALOX12CYP19A1ALDH1A1 | |
| (3R)-Sativanone SCHEMBL30635254 | 0.80 | PTPN1 (0.61) | PTPN1ALOX15ALOX12CYP19A1ALDH1A1 | |
| SCHEMBL572085 | 0.80 | PTPN1 (0.67) | PTPN1DYRK1ACYP19A1ALDH1A1MAPT | |
| SCHEMBL6142399 | 0.80 | CYP19A1 (0.65) | PTPN1ALOX15ALOX12CYP19A1ALDH1A1 | |
| SCHEMBL29737519 | 0.77 | TDP1 (0.53) | PTPN1ALOX12CYP19A1MEN1KMT2A | |
| SCHEMBL31238344 | 0.77 | PTPN1 (0.56) | PTPN1ALOX15ALOX12CYP19A1ALDH1A1 | |
| SCHEMBL30561814 | 0.75 | PTPN1 (0.60) | PTPN1ALOX15ALOX12CYP19A1ALDH1A1 | |
| SCHEMBL213646 | 0.75 | PTPN1 (0.60) | PTPN1ALOX15ALOX12CYP19A1ALDH1A1 | |
| Dihydrobiochanin A SCHEMBL30217535 | 0.75 | ALOX12 (0.67) | PTPN1ALOX15ALOX12CYP19A1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119925454-A | Application of cajan leaf in rats with chronic myelosuppression caused by MTX | 浙江中医药大学 | 2025-05-06 | — | — | CN | claimed |
| CN-102731460-A | Method for separating and purifying cajanol from pigeon pea rhizomes | UNIV NORTHEAST FORESTRY | 2012-10-17 | — | — | CN | claimed |
| CN-119925454-A | Application of cajan leaf in rats with chronic myelosuppression caused by MTX | 浙江中医药大学 | 2025-05-06 | — | — | CN | disclosed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | disclosed |
| US-20190275119-A1 | PROOXIDANT CANCER CHEMO-SUPPRESSORS AND CHEMO-PROTECTORS AND METHODS OF USE RELATED THERETO | HOWES RANDOLPH M (US) | 2019-09-12 | — | — | US | disclosed |
| WO-2017065516-A1 | COMPOSITION FOR PREVENTING OR TREATING GYNECOLOGICAL CANCERS AND MENOPAUSAL SYMPTOMS CONTAINING CAJANUS CAJAN EXTRACT OR COMPOUND ISOLATED THEREFROM AS ACTIVE INGREDIENT | 숙명여자대학교 산학협력단 | 2017-04-20 | — | — | WO | disclosed |
| WO-2017065516-A1 | COMPOSITION FOR PREVENTING OR TREATING GYNECOLOGICAL CANCERS AND MENOPAUSAL SYMPTOMS CONTAINING CAJANUS CAJAN EXTRACT OR COMPOUND ISOLATED THEREFROM AS ACTIVE INGREDIENT | 숙명여자대학교 산학협력단 | 2017-04-20 | — | — | WO | disclosed |
| US-20140234271-A1 | COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS | THE HOSPITAL FOR SICK CHILDREN (CA) | 2014-08-21 | — | — | US | disclosed |
| US-8748177-B2 | Compositions for proliferation of cells and related methods | THE HOSPITAL FOR SICK CHILDREN (CA) | 2014-06-10 | — | — | US | disclosed |
| EP-2598150-A2 | COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS | The Hospital For Sick Children (CA) | 2013-06-05 | — | — | EP | disclosed |
| CN-102731460-A | Method for separating and purifying cajanol from pigeon pea rhizomes | UNIV NORTHEAST FORESTRY | 2012-10-17 | — | — | CN | disclosed |
| CN-102731460-A | Method for separating and purifying cajanol from pigeon pea rhizomes | UNIV NORTHEAST FORESTRY | 2012-10-17 | — | — | CN | disclosed |
| WO-2012018643-A2 | COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS | THE HOSPITAL FOR SICK CHILDREN (CA) | 2012-02-09 | — | — | WO | disclosed |
| US-20110301105-A1 | COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS | THE HOSPITAL FOR SICK CHILDREN (CA) | 2011-12-08 | — | — | US | disclosed |
| CN-101497594-B | Method for extracting, separating and purifying genistein from pigeon pea rhizome | UNIV NORTHEAST FORESTRY | 2011-03-23 | — | — | CN | disclosed |
| CN-101172948-B | Method for separation and purification of cajanine and pinostrobin from extract of cajanus cajan branches and leaves | UNIV NORTHEAST FORESTRY | 2010-09-22 | — | — | CN | disclosed |
| WO-2010039679-A1 | COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS | THE HOSPITAL FOR SICK CHILDREN (CA) | 2010-04-08 | — | — | WO | disclosed |
| CN-101497594-A | Method for extracting, separating and purifying genistein from pigeon pea rhizome | UNIV NORTHEAST FORESTRY (CN) | 2009-08-05 | — | — | CN | disclosed |
| WO-2008100977-A2 | CARBAMATES THERAPEUTIC RELEASE AGENTS AS AMIDASE INHIBITORS | N.V. ORGANON (NL) | 2008-08-21 | — | — | WO | disclosed |
| CN-101172948-A | Method for separation and purification of cajanine and pinostrobin from extract of cajanus cajan branches and leaves | UNIV NORTHEAST FORESTRY (CN) | 2008-05-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140234271-A1 | COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS | MKI67, KRT18, PROX1 | PTPN1 3544/4885DYRK1A 2852/4885ALOX15 3682/4885 |
| US-20110301105-A1 | COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS | MKI67, KRT18, PROX1 | PTPN1 3544/4885DYRK1A 2852/4885ALOX15 3682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.